The study involved 250 children between the ages of 6 months and 35 months who had at least three bouts of middle-ear infections within six months, or at least four infections within a year.
Researchers randomly assigned the children to either undergo tympanostomy-tube replacement, or receive antibiotics.
Across the two-year study, children who received the ear tubes had an average recurrent infection rate of about 1.5, compared to about 1.7 among those who were treated with antibiotics. There was also no significant difference in how severe recurrent infections were, findings showed.
“The rate of episodes of acute otitis media during a 2-year period was not significantly lower with tympanostomy-tube placement than with medical management,” researchers concluded.
To view the full study, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
